Dipivefrine
From Wikipedia, the free encyclopedia
![]() |
|
Dipivefrine
|
|
Systematic (IUPAC) name | |
[2-(2,2-dimethylpropanoyloxy)-4- (1-hydroxy-2-methylamino-ethyl)- phenyl] 2,2-dimethylpropanoate | |
Identifiers | |
CAS number | |
ATC code | S01 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C19H29NO5 |
Mol. mass | 351.437 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
B(US) |
Legal status | |
Routes | ? |
Dipivefrine (Dipivefrin in the United States) is a prodrug of adrenaline, which is used to treat glaucoma. It is available as ophthalmic solution (eye drops).
Antiglaucoma preparations and miotics (S01E) | |
---|---|
Sympathomimetics | Apraclonidine, Brimonidine, Clonidine, Dipivefrine, Epinephrine |
Parasympathomimetics | Aceclidine, Acetylcholine, Carbachol, Demecarium, Echothiophate, Fluostigmine, Neostigmine, Paraoxon, Physostigmine, Pilocarpine |
Carbonic anhydrase inhibitors | Acetazolamide, Brinzolamide, Diclofenamide, Dorzolamide, Methazolamide |
Beta blocking agents | Befunolol, Betaxolol, Carteolol, Levobunolol, Metipranolol, Timolol |
Prostaglandin analogues | Bimatoprost, Latanoprost, Travoprost, Unoprostone |
Other agents | Dapiprazole, Guanethidine |